Anti-butyrophilin like 2 antibodies are used for the immunodetection of the protein encoded by the BTNL2 gene. In humans, the canonical protein has a reported length of 455 amino acid residues and a mass of 50.4 kDa. Its subcellular localization is in the membrane. Alternative splicing is reported to yield 6 different isoforms for this protein. It is reported to be expressed in the brain, heart, kidney, liver, pancreas, ovary, leukocyte, small intestine, testis and thymus. A member of the BTN/MOG protein family, it is a reported regulator of T-cell proliferation. Post-translational modifications have been described, including glycosylation. Other names for this target antigen include butyrophilin-like protein 2 and butyrophilin-like 2 (MHC class II associated). Gene orthologs have been identified in the mouse, rat, bovine and chimpanzee species. Some butyrophilin like 2 antibodies may have been used in research and have associated citations. These antibodies are most commonly used in Western Blot experiments, among other applications.